Replies to post #114711 on Biotech Values

[alertmeipp]

Interesting news. Paying a fee to get a formal timeline would be a welcome change.

[DewDiligence]

FoB Cheat Sheet

This chart shows why the hullabaloo over the 12-year exclusivity
period for US biologics is much ado about nothing (#msg-59912094).
For every big-selling biologic, US patent protection continues longer
than the statutory exclusivity period.



(The 12-year exclusivity could become consequential if the
US patents on these drugs were found to be unenforceable,
but there’s no indication that such an outcome is likely.)

Source: http://www.pharma-mag.com/Portals/0/Whitepapers/newport-biologics.pdf